These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18559393)

  • 1. Response to "MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation".
    Coltart I; Austin M; Shawcross DL
    Gut; 2008 Jul; 57(7):1024-5. PubMed ID: 18559393
    [No Abstract]   [Full Text] [Related]  

  • 2. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC; Cárdenas A; Guevara M; Quintó L; de Las Heras D; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Ginès P
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond.
    Huo TI; Lee SD; Lin HC
    Liver Int; 2008 May; 28(5):606-13. PubMed ID: 18433390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of prognosis of cirrhosis.
    Durand F; Valla D
    Semin Liver Dis; 2008 Feb; 28(1):110-22. PubMed ID: 18293281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
    Cai CJ; Chen HA; Lu MQ; Chen GH
    Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive biomarkers of liver fibrosis in liver transplant patients with hepatitis C: can we avoid liver biopsies?
    Berenguer M
    Dig Liver Dis; 2009 Mar; 41(3):226-8. PubMed ID: 19138576
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
    Xiol X; Gines P; Castells L; Twose J; Ribalta A; Fuentes-Arderiu X; Rodriguez S; Castellote J; Navasa M; Deulofeu R
    Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].
    Sun J; Guo ZH; Lai TS; Tang YQ; Su L; Huo F; Wang SP; Pu MS; Wen Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1731-2, 1742. PubMed ID: 18819907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients.
    Radvan M; Svoboda P; Radvanová J; Stumar J; Scheer P
    Hepatogastroenterology; 2009; 56(89):181-5. PubMed ID: 19453054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of recipient pretransplant MELD-AS score and graft size on the outcome of adult-to-adult living donor liver transplantation].
    Feng X; Wei YG; Li FQ; Yuan D; Jiang H; Du ZG; Yin J; Li B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):801-4. PubMed ID: 19024318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Zanello M; Ravaioli M; Capussotti L; Pinna AD
    Arch Surg; 2009 Jan; 144(1):57-63; discussion 63. PubMed ID: 19153326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically relevant differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease-sodium scores.
    Garritsen R; Tintu A; Metselaar H; Kazemier G
    Liver Transpl; 2009 Dec; 15(12):1903; author reply 1904. PubMed ID: 19938111
    [No Abstract]   [Full Text] [Related]  

  • 19. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.